TORONTO and GATINEAU, QC,
Feb. 10,
2025 /PRNewswire/ -- Converge Technology Solutions
Corp. ("Converge" or "the Company") (TSX: CTS) (FSE:
0ZB) (OTCQX: CTSDF), today announced preliminary results for the
fourth quarter ("Q4-2024") and fiscal year ended
December 31, 2024. The Company will hold a conference call to
discuss complete financial results for Q4-2024 and fiscal year
ended December 31, 2024 on Thursday,
March 6th, 2025 at 8:00am
EST. The call will be hosted by the Converge leadership
team, followed by a question-and-answer period. Converge will
report its financial results in the morning prior to the call.
Q4-2024 Preliminary Results:
- Gross sales1 is expected to be approximately
$1.1 billion, an increase of 2.5%
year-over-year.
- Revenue is expected to be approximately $680.8 million, an increase of 4.6%
year-over-year.
- Gross profit is expected to be approximately $178.6 million, a decline of 1.6%
year-over-year.
- Adjusted EBITDA1 is expected to be approximately
$47.9 million, an increase of 3.0%
year-over-year.
- Cash from operating activities is expected to be approximately
$57.0 million, representing 119% of
Adjusted EBITDA1.
- Loss before income taxes is expected to be approximately
$21.2 million, an increase of
$16.8 million year-over-year,
primarily driven by loss from investment in Portage CyberTech Inc.
("Portage") of approximately $24.0
million due to impairment charges.
Fiscal 2024 Preliminary Results:
- Gross sales1 is expected to be approximately
$4.1 billion, an increase of 2.1%
year-over-year.
- Revenue is expected to be approximately $2.6 billion, a decline of 4.2%
year-over-year.
- Gross profit is expected to be approximately $691.4 million, a decline of 1.6%
year-over-year.
- Adjusted EBITDA1 is expected to be approximately
$167.3 million, a decline of 1.7%
year-over-year.
- Cash from operating activities is expected to be approximately
$269.4 million, representing 161% of
Adjusted EBITDA1.
- Loss before income taxes is expected to be approximately
$200.5 million, an increase of
$182.0 million year-over-year,
primarily driven by impairment loss on the Company' German segment
of $176.1 million and loss from
investment in Portage of approximately $25.9
million due to impairment charges.
_________________________________
|
[1] This is a non-IFRS measures and
not a recognized, defined or a standardized measure under IFRS.
This non-IFRS financial measure reported by the Company are defined
in the "Non-IFRS Financial Measures" section of this press
release.
|
The above results are preliminary in nature and unaudited, and
are inherently uncertain due to a number of factors, and remain
subject to review by the Company's management, audit committee and
board of directors and the completion of regular financial closing
and review procedures and audit procedures for Q4-2024 and fiscal
year ended December 31, 2024, as
applicable. These estimates are not a comprehensive statement of
the Company's financial results for Q4-2024 and fiscal year
December 31, 2024 The preliminary
unaudited figures disclosed herein should not be viewed as a
substitute for audited financial statements prepared in accordance
with generally accepted accounting principles. Additional
adjustments to the preliminary unaudited figures presented above
may be identified, and final results for the relevant fiscal
periods may differ materially from these preliminary unaudited
figures and will not be finalized until after the Company completes
its normal year-end accounting procedures, including execution of
internal controls over financial reporting. These preliminary
unaudited figures are intended to provide information about
management's current expectations regarding certain aspects of
Converge's financial performance. Reliance on the information
presented herein may not be appropriate for other purposes. Please
see the section below entitled "Forward- Looking Information".
The Company will provide additional discussion and analysis
regarding its fourth quarter results when it reports its complete
financial results for Q4-2024 and fiscal year ended
December 31, 2024.
Conference Call Details:
Date: Thursday, March 6th, 2025
Time: 8:00 AM Eastern Standard
Time
Participant Webcast Link:
Webcast Link –
https://app.webinar.net/5dw46kbzGAR
Participant Dial-in Details with Operator
Assistance:
Conference ID: 07389
Toronto: 1-416-945-7677
North American Toll Free: 1-888-699-1199
International Toll-Free Numbers:
Germany: 498005889782
Ireland: 35315251826
Spain: 34917918582
Switzerland: 41432107274
United Kingdom: 448002797040
You may register and enter your phone number to receive an
instant automated call back via
https://emportal.ink/3WRn7js
Recording Playback:
Webcast Link - https://app.webinar.net/5dw46kbzGAR
Toronto: 1-289-819-1450
North American Toll Free: 1-888-660-6345
Replay Code: 07389 #
Expiry Date: March 13th,
2025
Please connect at least 15 minutes prior to the conference call
to ensure time for any software download that may be required to
access the webcast. A live audio webcast accompanied by
presentation slides and archive of the conference call and webcast
will be available by visiting the Company's website
at https://convergetp.com/investor-relations/.
About Converge
Converge Technology Solutions Corp.
is reimagining the way businesses think about IT—a vision driven by
people, for people. Since 2017, we've focused on delivering
outcomes-driven solutions that tackle human-centered challenges. As
a services-led, software-enabled, IT & Cloud Solutions
provider, we combine deep expertise, local connections, and global
resources to deliver industry-leading solutions.
Through advanced analytics, artificial intelligence (AI),
cloud platforms, cybersecurity, digital infrastructure, and
workplace transformation, we empower businesses across industries
to innovate, streamline operations, and achieve meaningful results.
Our AIM (Advise, Implement, Manage) methodology ensures solutions
are tailored to our customers' specific needs, aligning with
existing systems to drive success without complexity.
Discover IT reimagined with Converge—where innovation meets
people. Learn more at convergetp.com.
For further information:
Investor Relations
investors@convergetp.com
Phone: 416-360-1495
Non-IFRS Financial Measures
This press release refers to certain performance indicators
including Adjusted EBITDA and gross sales that do not have any
standardized meaning prescribed by IFRS and may not be comparable
to similar measures presented by other companies. Management
believes that these measures are useful to most shareholders,
creditors, and other stakeholders in analyzing the Company's
operating results and can highlight trends in its core business
that may not otherwise be apparent when relying solely on IFRS
financial measures. The Company also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers.
Management also uses non-IFRS measures in order to facilitate
operating performance comparisons from period to period, prepare
annual operating budgets and assess the ability to meet capital
expenditure and working capital requirements. These non-IFRS
financial measures should not be considered as an alternative to
the consolidated income (loss) or any other measure of performance
under IFRS. Investors are encouraged to review the Company's
financial statements and disclosures in their entirety, are
cautioned not to put undue reliance on non-IFRS measures and view
them in conjunction with the most comparable IFRS financial
measures.
Please see "Non-IFRS Financial & Supplementary Financial
Measures" and "Summary of Consolidated Financial Results" in the
Company's most recent Management Discussion and Analysis, which is
available on the Company's profile on SEDAR+ at www.sedarplus.ca,
for further details on certain non-IFRS measures, which information
is incorporated by reference herein.
Adjusted EBITDA
Adjusted EBITDA represents net income or loss adjusted to
exclude amortization, depreciation, net finance expense, foreign
exchange gains and losses, other expenses and income, share-based
compensation expense, income tax expense or recovery, change in
fair value of contingent consideration, impairment loss, gain or
loss on loss of control of subsidiary, income or loss from
investment in associates and acquisition, integration,
restructuring and other expenses. Acquisition and transaction
related costs primarily consists of acquisition-related
compensation tied to continued employment of pre-existing
shareholders of the acquiree not included in the total purchase
consideration and professional fees. Integration costs primarily
consist of professional fees incurred related to integration of
acquisitions completed. Restructuring costs mainly represent
employee exit costs as a result of synergies created from
acquisitions and organizational changes. Adjusted EBITDA is not a
recognized, defined, or standardized measure under IFRS. The
Company's definition of Adjusted EBITDA will likely differ from
that used by other companies and therefore comparability may be
limited.
Adjusted EBITDA is not a recognized, defined, or standardized
measure under IFRS. The Company's definition of Adjusted EBITDA
will likely differ from that used by other companies and therefore
comparability may be limited.
Adjusted EBITDA should not be considered a substitute for or in
isolation from measures prepared in accordance with IFRS.
The IFRS measure most directly comparable to Adjusted EBITDA
presented in the Company's financial statements is net (loss)
income before taxes.
The Company has reconciled Adjusted EBITDA to the most
comparable IFRS financial measure as follows:
(000' of
CAD)
|
Q4
2023
$
|
Fiscal
2023
$
|
Net (loss) income
before taxes
|
(4,454)
|
(18,565)
|
Depreciation and
amortization
|
29,212
|
111,451
|
Depreciation included
in cost of sales
|
2,427
|
8,532
|
Finance expense,
net
|
10,355
|
41,225
|
Acquisition,
integration, restructuring and other
|
2,679
|
13,648
|
Change in fair value of
contingent consideration
|
5,464
|
14,673
|
Share-based
compensation
|
954
|
3,692
|
Other loss (income),
net
|
(132)
|
(4,362)
|
Adjusted
EBITDA
|
46,505
|
170,294
|
Gross sales
Gross sales, which is a non-IFRS measure, reflects the gross
amount billed to customers, adjusted for amounts deferred or
accrued. The Company believes gross sales is a useful alternative
financial metric to net revenue, the IFRS measure, as it better
reflects volume fluctuations as compared to net revenue. Under the
applicable IFRS 15 'principal vs agent' guidance, the principal
records revenue on a gross basis and the agent records commission
on a net basis. In transactions where Converge is acting as an
agent between the customer and the vendor, net revenue is
calculated by reducing gross sales by the cost of sale
amount.
The Company has reconciled Gross sales to the most comparable
IFRS financial measure as follows:
(000' of
CAD)
|
Q4
2023
$
|
Fiscal
2023
$
|
Gross sales
|
1,078,663
|
4,037,921
|
Less: adjustment for
sales transacted as agent
|
427,573
|
1,332,714
|
Revenue
|
651,090
|
2,705,207
|
Forward-Looking Information
This press release contains certain "forward-looking
information" and "forward-looking statements" (collectively,
"forward-looking statements") within the meaning of
applicable Canadian securities legislation regarding Converge and
its business. Any statement that involves discussions with respect
to predictions, expectations, beliefs, plans, projections,
objectives, assumptions, future events or performance (often but
not always using phrases such as "expects", or "does not expect",
"is expected" "anticipates" or "does not anticipate", "plans",
"budget", "scheduled", "forecasts". "estimates", "believes" or
"intends" or variations of such words and phrases or stating that
certain actions, events or results "may" or "could", "would",
"might" or "will" be taken to occur or be achieved) are not
statements of historical fact and may be forward-looking
statements. Specifically, statements regarding Converge's expected
revenue, gross profit, gross sales, Adjusted EBITDA, cash from
operating activities and loss before income taxes are considered
forward-looking information. The forward-looking information,
including management's assessments of, and outlook for, revenue,
gross profit, gross sales, Adjusted EBITDA, cash from operating
activities and loss before income taxes are based on management's
opinions, estimates and assumptions, including, but not limited to:
(i) Converge's results of operations will continue as expected,
(ii) the Company will continue to effectively execute against its
key strategic growth priorities, (iii) the Company will continue to
retain and grow its existing customer base and market share, (iv)
the Company will be able to take advantage of future prospects and
opportunities, and realize on synergies, including with respect of
acquisitions, (v) there will be no changes in legislative or
regulatory matters that negatively impact the Company's business,
(vi) current tax laws will remain in effect and will not be
materially changed, (vii) economic conditions will remain
relatively stable throughout the period, (vii) the industries
Converge operates in will continue to grow consistent with past
experience, and (ix) those assumptions described under the heading
"About Forward-Looking Information" in the Company's Management
Discussion and Analysis for the three and nine months ended
September 30, 2024. While these
opinions, estimates and assumptions are considered by the Company
to be appropriate and reasonable in the circumstances as of the
date of this press release, they are subject to known and unknown
risks, uncertainties, assumptions and other factors that may cause
the actual results, levels of activity, performance, or
achievements to be materially different from those expressed or
implied by such forward-looking information.
The forward looking information, including the achievement of
expected revenue, gross profit, gross sales, Adjusted EBITDA, cash
from operating activities and loss before income taxes set out
above, are subject to significant risks including, without
limitation: that the Company will be unable to effectively execute
against its key strategic growth priorities; the Company will be
unable to continue to retain and grow its existing customer base
and market share; risks related to the Company's business and
financial position; that the Company may not be able to accurately
predict its rate of growth and profitability; risks related to
economic and political uncertainty; income tax related risks; and
those risk factors discussed in greater detail under the "Risk
Factors" section of the Company's most recent annual information
form and under the heading "Risks and Uncertainties" in the
Company's most recent Management Discussion and Analysis, which are
each available under the Company's profile on SEDAR+ at
www.sedarplus.ca. Many of these risks are beyond the Company's
control.
If any of these risks or uncertainties materialize, or if the
opinions, estimates or assumptions underlying the forward-looking
information prove incorrect, actual results or future events might
vary materially from those anticipated in the forward-looking
information. Although the Company has attempted to identify
important risk factors that could cause actual results to differ
materially from those contained in forward-looking information,
there may be other risk factors not presently known to the Company
or that the Company presently believes are not material that could
also cause actual results or future events to differ materially
from those expressed in such forward-looking information.
Although the Company bases these forward-looking statements on
assumptions that it believes are reasonable when made, the Company
cautions investors that forward-looking statements are not
guarantees of future performance and that its actual results of
operations, financial condition and liquidity may differ materially
from those made in or suggested by the forward-looking statements
contained in this press release. In addition, even if the Company's
results of operations, financial condition and liquidity are
consistent with the forward-looking statements contained in this
press release, those results of developments may not be indicative
of results in subsequent periods.
There can be no assurance that such information will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such information. No
forward-looking statement is a guarantee of future results.
Accordingly, you should not place undue reliance on forward-looking
information, which speaks only as of the date made. The
forward-looking information contained in this press release
represents the company's expectations as of the date specified
herein, and are subject to change after such date. However, the
Company disclaims any intention or obligation or undertaking to
update or revise any forward-looking information or to publicly
announce the results of any revisions to any of those statements,
whether as a result of new information, future events or otherwise,
except as required under applicable securities laws. Comparisons of
results for current and any prior periods are not intended to
express any future trends or indications of future performance,
unless specifically expressed as such, and should only be viewed as
historical data.
All of the forward-looking information contained in this press
release is expressly qualified by the foregoing cautionary
statements.
View original
content:https://www.prnewswire.co.uk/news-releases/converge-reports-preliminary-fourth-quarter-and-fiscal-year-2024-financial-results-and-conference-call-details-302371942.html